Pages that link to "Q58877117"
Jump to navigation
Jump to search
The following pages link to Increased activation of p38 MAPK in COPD (Q58877117):
Displaying 50 items.
- The Novartis view on emerging drugs and novel targets for the treatment of chronic obstructive pulmonary disease (Q26828971) (← links)
- IL-13-induced airway mucus production is attenuated by MAPK13 inhibition (Q27675276) (← links)
- Glucocorticoid insensitivity as a future target of therapy for chronic obstructive pulmonary disease (Q28761895) (← links)
- p38 mitogen-activated protein kinase determines the susceptibility to cigarette smoke-induced emphysema in mice (Q33624820) (← links)
- Dual effect of neutrophils on pIgR/secretory component in human bronchial epithelial cells: role of TGF-beta (Q34038314) (← links)
- Comparison of the anti-inflammatory effects of Cilomilast, Budesonide and a p38 Mitogen activated protein kinase inhibitor in COPD lung tissue macrophages (Q34475700) (← links)
- Evaluation of glucocorticoid receptor function in COPD lung macrophages using beclomethasone-17-monopropionate (Q34738020) (← links)
- Novel function for the p38-MK2 signaling pathway in circulating CD1c+ (BDCA-1+) myeloid dendritic cells from healthy donors and advanced cancer patients; inhibition of p38 enhances IL-12 whilst suppressing IL-10. (Q34983989) (← links)
- Epithelial cell senescence impairs repair process and exacerbates inflammation after airway injury (Q35054708) (← links)
- Reversal of corticosteroid insensitivity by p38 MAPK inhibition in peripheral blood mononuclear cells from COPD. (Q35067454) (← links)
- Elevated plasma levels of pigment epithelium-derived factor correlated with inflammation and lung function in COPD patients (Q35201511) (← links)
- Protein phosphatase 2A regulates innate immune and proteolytic responses to cigarette smoke exposure in the lung (Q35839542) (← links)
- Berberine attenuates cigarette smoke-induced airway inflammation and mucus hypersecretion in mice. (Q35959271) (← links)
- Oral and inhaled p38 MAPK inhibitors: effects on inhaled LPS challenge in healthy subjects (Q36042965) (← links)
- Murine cytomegalovirus (MCMV) infection upregulates P38 MAP kinase in aortas of Apo E KO mice: a molecular mechanism for MCMV-induced acceleration of atherosclerosis (Q36113031) (← links)
- Differential Effects of p38, MAPK, PI3K or Rho Kinase Inhibitors on Bacterial Phagocytosis and Efferocytosis by Macrophages in COPD. (Q36146801) (← links)
- Population PK-PD Model for Tolerance Evaluation to the p38 MAP Kinase Inhibitor BCT197. (Q36595924) (← links)
- Cutting Edge: CLEC5A Mediates Macrophage Function and Chronic Obstructive Pulmonary Disease Pathologies (Q36767675) (← links)
- Regulation of Wnt4 in chronic obstructive pulmonary disease (Q36860267) (← links)
- Electronic cigarette exposure triggers neutrophil inflammatory responses. (Q36907377) (← links)
- Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease (Q37012728) (← links)
- Role of IL-18 in second-hand smoke-induced emphysema (Q37056441) (← links)
- Inhibition of lipopolysaccharide-stimulated chronic obstructive pulmonary disease macrophage inflammatory gene expression by dexamethasone and the p38 mitogen-activated protein kinase inhibitor N-cyano-N'-(2-{[8-(2,6-difluorophenyl)-4-(4-fluoro-2-me (Q37192755) (← links)
- Elastase induced lung epithelial cell apoptosis and emphysema through placenta growth factor (Q37212013) (← links)
- Neutral sphingomyelinase-2, acid sphingomyelinase, and ceramide levels in COPD patients compared to controls (Q37248481) (← links)
- How ERK1/2 activation controls cell proliferation and cell death: Is subcellular localization the answer? (Q37309204) (← links)
- Treating patients with respiratory disease who smoke (Q37362600) (← links)
- Therapeutic perspectives in bronchial vascular remodeling in COPD. (Q37362620) (← links)
- Update in chronic obstructive pulmonary disease 2008. (Q37422824) (← links)
- Silymarin attenuates cigarette smoke extract-induced inflammation via simultaneous inhibition of autophagy and ERK/p38 MAPK pathway in human bronchial epithelial cells (Q37428190) (← links)
- Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future. (Q37532050) (← links)
- The cytokine network in chronic obstructive pulmonary disease (Q37589389) (← links)
- Corticosteroid effects on COPD alveolar macrophages: dependency on cell culture methodology (Q37731160) (← links)
- What's new in atopic eczema? (Q37740142) (← links)
- Overcoming reduced glucocorticoid sensitivity in airway disease: molecular mechanisms and therapeutic approaches. (Q37756117) (← links)
- What is the Potential for Inhaled P38 Inhibitors in the Treatment of Chronic Obstructive Pulmonary Disease? (Q37937555) (← links)
- Emerging drugs for chronic obstructive pulmonary disease. (Q37984088) (← links)
- p38 MAPK inhibitors, IKK2 inhibitors, and TNFα inhibitors in COPD. (Q37988188) (← links)
- Corticosteroid resistance and novel anti-inflammatory therapies in chronic obstructive pulmonary disease: current evidence and future direction. (Q38021518) (← links)
- New anti-inflammatory targets for chronic obstructive pulmonary disease. (Q38131512) (← links)
- Beneficial role of vitamin D3 in the prevention of certain respiratory diseases (Q38140574) (← links)
- Neutrophils and emerging targets for treatment in chronic obstructive pulmonary disease. (Q38156225) (← links)
- Therapeutic potential of p38 MAP kinase inhibition in the management of cardiovascular disease (Q38185979) (← links)
- Investigational p38 inhibitors for the treatment of chronic obstructive pulmonary disease (Q38323383) (← links)
- Roles of p38α mitogen-activated protein kinase in mouse models of inflammatory diseases and cancer. (Q38366515) (← links)
- An increased ratio of serum miR-21 to miR-181a levels is associated with the early pathogenic process of chronic obstructive pulmonary disease in asymptomatic heavy smokers (Q38479530) (← links)
- Pharmacological basis and scientific rationale underlying the targeted use of inhaled corticosteroid/long-acting β2-adrenergic agonist combinations in chronic obstructive pulmonary disease treatment. (Q38550921) (← links)
- Secondhand Smoke-Prevalent Polycyclic Aromatic Hydrocarbon Binary Mixture-Induced Specific Mitogenic and Pro-inflammatory Cell Signaling Events in Lung Epithelial Cells. (Q38711167) (← links)
- In vitro modeling of COPD inflammation and limitation of p38 inhibitor - SB203580 (Q38769714) (← links)
- Transcriptional and posttranscriptional regulation of CXCL8/IL-8 gene expression induced by connective tissue growth factor (Q38864535) (← links)